Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$98.98 - $115.74 $8.02 Million - $9.38 Million
81,028 Added 150.8%
134,760 $15.6 Million
Q2 2023

Aug 11, 2023

BUY
$96.34 - $112.38 $5.18 Million - $6.04 Million
53,732 New
53,732 $5.53 Million
Q4 2022

Feb 10, 2023

BUY
$62.39 - $113.8 $5.51 Million - $10 Million
88,282 Added 508.68%
105,637 $12 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $1.02 Million - $1.47 Million
17,355 New
17,355 $1.07 Million
Q2 2022

Aug 12, 2022

SELL
$79.4 - $116.36 $2.88 Million - $4.22 Million
-36,257 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $3.13 Million - $3.98 Million
36,257 New
36,257 $3.81 Million
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $6.71 Million - $8.17 Million
-68,116 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $4.7 Million - $5.64 Million
-51,128 Reduced 42.88%
68,116 $7.46 Million
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $9.79 Million - $10.9 Million
113,471 Added 1965.55%
119,244 $11.2 Million
Q1 2021

May 17, 2021

SELL
$71.83 - $95.48 $1.27 Million - $1.69 Million
-17,739 Reduced 75.45%
5,773 $531,000
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $18.5 Million - $23.4 Million
-276,812 Reduced 92.17%
23,512 $1.72 Million
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $16.6 Million - $24 Million
300,324 New
300,324 $23.3 Million
Q3 2019

Nov 14, 2019

SELL
$23.0 - $27.97 $3.75 Million - $4.56 Million
-163,059 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $3.72 Million - $4.64 Million
163,059 New
163,059 $3.92 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.